ACRUX Ltd (ACR) - Total Liabilities
Based on the latest financial reports, ACRUX Ltd (ACR) has total liabilities worth AU$6.20 Million AUD (≈ $4.39 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are ACRUX Ltd's assets to evaluate the company's liquid asset resilience ratio.
ACRUX Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how ACRUX Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ACR total assets.
ACRUX Ltd Competitors by Total Liabilities
The table below lists competitors of ACRUX Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GlucoTrack Inc
NASDAQ:GCTK
|
USA | $3.24 Million |
|
XMReality AB
ST:XMR
|
Sweden | Skr11.84 Million |
|
Schroder Income Growth Fund
LSE:SCF
|
UK | GBX29.84 Million |
|
Telo Genomics Corp
V:TELO
|
Canada | CA$633.60K |
|
DGB Asia Bhd
KLSE:0152
|
Malaysia | RM99.36 Million |
|
Mlabs Systems Bhd
KLSE:0085
|
Malaysia | RM10.41 Million |
|
Xamble Group Ltd
AU:XGL
|
Australia | AU$4.04 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down ACRUX Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ACRUX Ltd balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.19 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.86 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ACRUX Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ACRUX Ltd (2001–2025)
The table below shows the annual total liabilities of ACRUX Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$6.20 Million ≈ $4.39 Million |
+9.06% |
| 2024-06-30 | AU$5.69 Million ≈ $4.02 Million |
+1.50% |
| 2023-06-30 | AU$5.60 Million ≈ $3.96 Million |
-9.38% |
| 2022-06-30 | AU$6.18 Million ≈ $4.37 Million |
+7.89% |
| 2021-06-30 | AU$5.73 Million ≈ $4.06 Million |
+1.04% |
| 2020-06-30 | AU$5.67 Million ≈ $4.01 Million |
+127.15% |
| 2019-06-30 | AU$2.50 Million ≈ $1.77 Million |
-0.87% |
| 2018-06-30 | AU$2.52 Million ≈ $1.78 Million |
-25.50% |
| 2017-06-30 | AU$3.38 Million ≈ $2.39 Million |
-64.34% |
| 2016-06-30 | AU$9.48 Million ≈ $6.71 Million |
+20.48% |
| 2015-06-30 | AU$7.87 Million ≈ $5.57 Million |
-29.51% |
| 2014-06-30 | AU$11.16 Million ≈ $7.90 Million |
+81.76% |
| 2013-06-30 | AU$6.14 Million ≈ $4.35 Million |
+13.83% |
| 2012-06-30 | AU$5.40 Million ≈ $3.82 Million |
-59.38% |
| 2011-06-30 | AU$13.28 Million ≈ $9.40 Million |
+323.57% |
| 2010-06-30 | AU$3.14 Million ≈ $2.22 Million |
-15.86% |
| 2009-06-30 | AU$3.73 Million ≈ $2.64 Million |
+18.02% |
| 2008-06-30 | AU$3.16 Million ≈ $2.23 Million |
+48.75% |
| 2007-06-30 | AU$2.12 Million ≈ $1.50 Million |
-19.92% |
| 2006-06-30 | AU$2.65 Million ≈ $1.88 Million |
+64.47% |
| 2005-06-30 | AU$1.61 Million ≈ $1.14 Million |
+19.52% |
| 2004-06-30 | AU$1.35 Million ≈ $954.23K |
+14.18% |
| 2003-06-30 | AU$1.18 Million ≈ $835.75K |
+35.69% |
| 2002-06-30 | AU$870.46K ≈ $615.91K |
+17.47% |
| 2001-06-30 | AU$741.00K ≈ $524.30K |
-- |
About ACRUX Ltd
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more